Tomoyuki Kaneko

11PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer diagnosisObstetrics and gynaecologyOther philosophy and religious studies not elsewhere classifiedPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Integrating Molecular Classification Based on FGFR3, KRAS, HRAS, and TP53 Mutation With TNM Staging Modestly Improves Prediction of Prognosis of Upper Tract Urothelial Carcinoma After Surgery.

|Jul 29, 2025
Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study.

Kazuki Honda, Taketo Kawai, Satoru Taguchi

|Nov 22, 2024
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.

Satoru Taguchi, Taketo Kawai, Yoshiki Ambe

|Sep 03, 2024
Vesicovaginal fistula and bladder calculus formation secondary to long-term retention of an intrauterine device.

Masahiro Goto, Tomoyuki Kaneko, Naoki Yamamine

|Aug 28, 2024
Oncologic and Functional Outcomes of Salvage Robot-Assisted Radical Prostatectomy: Report of the First 10 Cases.

Takahiro Oshina, Yuta Yamada, Tetsuya Fujimura

|Sep 23, 2023
Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.

Satoru Taguchi, Taketo Kawai, Yoshiki Ambe

Pageof 2

Frequent Collaborators

7 joint publications

Taketo Kawai

6 joint publications

Satoru Taguchi

4 joint publications

Tohru Nakagawa

3 joint publications

Kenya Yamaguchi